Sep 9, 2020 Cellectar Reports Data on CLR 131 Phase 2 CLOVER-1 Study in Triple Class Refractory Multiple Myeloma Patients Learn More
Aug 17, 2020 Cellectar Presents Poster at the AACR VIRTUAL MEETING: ADVANCES IN MALIGNANT LYMPHOMA Learn More
Aug 10, 2020 Cellectar Reports Second Quarter 2020 Financial Results and Provides a Corporate Update Learn More